Pretax income is the income that a company earns before paying income taxes. Geovax Labs's pretax income for the
three
months ended in Dec. 2024 was $-8.26 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2024 was $-24.99 Mil.
Geovax Labs's pretax margin was -956.37%.
During the past 13 years, Geovax Labs's highest Pretax Margin was -162.17%. The lowest was -17098.78%. And the median was -394.69%.
Geovax Labs Pre-Tax Income Historical Data
The historical data trend for Geovax Labs's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Geovax Labs's Pre-Tax Income
For the Biotechnology subindustry, Geovax Labs's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Geovax Labs's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Geovax Labs's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Geovax Labs's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-24.99 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Geovax Labs (NAS:GOVX) Pre-Tax Income Explanation
Geovax Labs's Pretax Margin for the quarter that ended in Dec. 2024 is calculated as
During the past 13 years, Geovax Labs's highest Pretax Margin was -162.17%. The lowest was -17098.78%. And the median was -394.69%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Geovax Labs Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Geovax Labs's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
GOVX has been successfully added to your 